Diisopropylfluorophosphate-induced depression of segmental monosynaptic transmission in neonatal rat spinal cord is also mediated by increased axonal activity.
Involvement of dorsal and ventral root activity for the depressant action of diisopropylfluorophosphate (DFP) on synaptic transmission was examined using in vitro spinal cord/root preparations. Superfusion of DFP produced a dose-dependent depression of monosynaptic reflex (MSR) and maximal depression of about 80% occurred at 1000 microM. The concentration to produce 50% of the maximal inhibition was about 100 microM of DFP. The DFP (100 microM)-induced depression of MSR was reversed by atropine (0.5 microM) but not by mecamylamine (0.5 microM). Contrary to the action on MSR, DFP potentiated the ventral root potential and 1st peak of dorsal root potential. The maximal potentiation was about 25% of control in both the root potentials at 100 microM of DFP. However, the second peak of dorsal root potential was slightly depressed (10-20% of control) by DFP (1-1000 microM). Further, the cords treated with DFP (100 microM) showed significant decrease in the cholinesterase (ChE) activity (27% of control). Results suggest that the DFP-induced depression was mediated at least by two different mechanisms, one through the inhibition of ChE activity and the other through the activation axonal activity having inhibitory inputs to the segmental synaptic transmission. These inputs mediate their action through muscarinic receptors.
Deshpande
S B
SB
Department of Physiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, India.
DasGupta
S
S
D000818:Animals; D000831:Animals, Newborn; D001369:Axons / Q000187:drug effects* / Q000502:physiology*; D002800:Cholinesterase Inhibitors / Q000633:toxicity; D007531:Isoflurophate / Q000633:toxicity*; D051381:Rats; D012023:Reflex, Monosynaptic / Q000187:drug effects*; D013116:Spinal Cord / Q000187:drug effects*; D013126:Spinal Nerve Roots / Q000187:drug effects; D009435:Synaptic Transmission / Q000187:drug effects*; D004561:Transcutaneous Electric Nerve Stimulation
D002800:Cholinesterase Inhibitors; D007531:Isoflurophate